These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20579252)

  • 21. Resolving ethical issues in stem cell clinical trials: the example of Parkinson disease.
    Lo B; Parham L
    J Law Med Ethics; 2010; 38(2):257-66. PubMed ID: 20579249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 23. Improving protection for research subjects.
    Steinbrook R
    N Engl J Med; 2002 May; 346(18):1425-30. PubMed ID: 11986426
    [No Abstract]   [Full Text] [Related]  

  • 24. What's in a name?
    Benham B
    Am J Bioeth; 2008 Apr; 8(4):47-9. PubMed ID: 18576257
    [No Abstract]   [Full Text] [Related]  

  • 25. Ethics committees and clinical trials registration in India: opportunities, obligations, challenges and solutions.
    Tharyan P
    Indian J Med Ethics; 2007; 4(4):168-9. PubMed ID: 18630235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Children as research subjects: guinea pigs or therapeutic orphans?
    Tauer C
    Bioeth Exam; 2003; 7(2):1-2, 4-5. PubMed ID: 15025108
    [No Abstract]   [Full Text] [Related]  

  • 27. Institutional review board consideration of chart reviews, case reports, and observational studies.
    Neff MJ
    Respir Care; 2008 Oct; 53(10):1350-3. PubMed ID: 18811999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction to special issue of Accountability in Research on the review and approval of biomedical research proposals: a call for a centralized national human research protections system.
    Mann H; Shamoo AE
    Account Res; 2006; 13(1):1-9. PubMed ID: 16770856
    [No Abstract]   [Full Text] [Related]  

  • 29. Stem-cell therapy takes off in Texas.
    Cyranoski D
    Nature; 2012 Feb; 483(7387):13-4. PubMed ID: 22382952
    [No Abstract]   [Full Text] [Related]  

  • 30. Data from human research projects will now be available to public.
    Maloney DM
    Hum Res Rep; 2001 Apr; 16(4):1-2. PubMed ID: 11883453
    [No Abstract]   [Full Text] [Related]  

  • 31. US clinical-research system in need of review.
    Ammann AJ
    Nature; 2013 Jun; 498(7452):7. PubMed ID: 23739388
    [No Abstract]   [Full Text] [Related]  

  • 32. The Office of Human Research Protections.
    Chamberlain B
    Clin Nurse Spec; 2008; 22(6):268. PubMed ID: 18955842
    [No Abstract]   [Full Text] [Related]  

  • 33. Duke's hazards. Did medical experiments put patients needlessly at risk?
    Kaplan S; Brownlee S
    US News World Rep; 1999 May; 126(20):66-8, 70. PubMed ID: 10387890
    [No Abstract]   [Full Text] [Related]  

  • 34. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 35. [Independent ethics committees for clinical research in Argentina. An evaluation and a system to guarantee their independence].
    Gonorazky SE
    Medicina (B Aires); 2008; 68(2):113-9. PubMed ID: 18499958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials face heightened scrutiny as science and commerce appear to merge.
    Lorman AJ
    J Biolaw Bus; 2001; 4(4):23-32. PubMed ID: 12751494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research, regulations, and responsibility: confronting the compliance myth--a reaction to Professor Gatter.
    Koski G
    Emory Law J; 2003; 52(1):403-16. PubMed ID: 15575097
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer trials and the Institutional Review Board (IRB).
    Kurtzman S; Lazzarini Z
    Cancer Treat Res; 2007; 132():11-30. PubMed ID: 17305015
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.